Studies on the Egyptian Nigella sativa L. IV. Some pharmacological properties of the seeds' active principle in comparison to its dihydro compound and its polymer.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D008297:Male; D010946:Plants, Medicinal; D011809:Quinones / Q000494:pharmacology* / Q000633:toxicity*; D051381:Rats
D000893:Anti-Inflammatory Agents; D006634:Histamine H1 Antagonists; D011809:Quinones